Our agile research team has miles of experience.

We treat every project as a custom project.
Deep knowledge of pre-clinical technologies and methods.
Home 2018-01-20T06:07:25+00:00


Aragen’s RapTr™ Cell Line Development services combine the proven CHO-DG44 host cell line and vector combination with an innovative clone selection process that delivers high titers at every stage from Discovery to the Clinic.

Molecular Med Tri-Con
February 11-16, 2018 |
San Francisco, CA

Press Releases

Aragen Bioscience Announces AAALAC Accreditation

RapTr Cell Line Development Services Introduced